Secondary prophylaxis with warfarin for venous thromboembolism

被引：25

作者：

Buller, HR

Prins, MH

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands

[2] Univ Maastricht, Acad Hosp Maastricht, Dept Clin Epidemiol & Med Technol, Maastricht, Netherlands

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 349卷 / 07期

关键词：

D O I：

10.1056/NEJMe038112

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：702 / 704

页数：3

共 10 条

[1] Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. [J].

Agnelli, G ;

Prandoni, P ;

Santamaria, MG ;

Bagatella, P ;

Iorio, A ;

Bazzan, M ;

Moia, M ;

Guazzaloca, G ;

Bertoldi, A ;

Tomasi, C ;

Scannapieco, G ;

Ageno, W ;

Ascani, A ;

Villalta, S ;

Frulla, M ;

Mosena, L ;

Girolami, A ;

Vaccarino, A ;

Alatri, A ;

Palareti, G ;

Marchesi, M ;

Ambrosio, GB ;

Parisi, R ;

Doria, S ;

Steidl, L ;

Ambrosini, F ;

Silingardi, M ;

Ghirarduzzi, A ;

Iori, I .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :165-169

[2]

BARRITT DW, 1960, LANCET, V1, P1309

[3] ACENOCOUMAROL AND HEPARIN COMPARED WITH ACENOCOUMAROL ALONE IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].

BRANDJES, DPM ;

HEIJBOER, H ;

BULLER, HR ;

DERIJK, M ;

JAGT, H ;

TENCATE, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1485-1489

[4]

HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602

[5] DIFFERENT INTENSITIES OF ORAL ANTICOAGULANT-THERAPY IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].

HULL, R ;

HIRSH, J ;

JAY, R ;

CARTER, C ;

ENGLAND, C ;

GENT, M ;

TURPIE, AGG ;

MCLOUGHLIN, D ;

DODD, P ;

THOMAS, M ;

RASKOB, G ;

OCKELFORD, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (27) :1676-1681

[6] Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism [J].

Kearon, C ;

Ginsberg, JS ;

Kovacs, MJ ;

Anderson, DR ;

Wells, P ;

Julian, JA ;

MacKinnon, B ;

Weitz, JI ;

Crowther, MA ;

Dolan, S ;

Turpie, AG ;

Geerts, W ;

Solymoss, S ;

van Nguyen, P ;

Demers, C ;

Kahn, SR ;

Kassis, J ;

Rodger, M ;

Hambleton, J ;

Gent, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07) :631-639

[7]

LAGERSTEDT CI, 1985, LANCET, V2, P515

[8]

Prins MH, 1999, THROMB HAEMOSTASIS, V82, P892

[9] Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism [J].

Ridker, PM ;

Goldhaber, SZ ;

Danielson, E ;

Rosenberg, Y ;

Eby, CS ;

Deitcher, SR ;

Cushman, M ;

Moll, S ;

Kessler, CM ;

Elliott, CG ;

Paulson, R ;

Wong, T ;

Bauer, KA ;

Schwartz, BA ;

Miletich, JP ;

Bounameaux, H ;

Glynn, RJ ;

Ridker, PM ;

Glynn, RJ ;

Danielson, EM ;

Bates, D ;

Christen, W ;

DeFonce, P ;

Griffin, W ;

Jackson, F ;

Murray, A ;

Taylor, K ;

Johnson, K ;

McKenna, K ;

Pierre, J ;

Holman, B ;

Dessources, F ;

Quinn, P ;

Laurinaitis, T ;

MacFadyen, J ;

Eby, C ;

Miletich, JP ;

Porche-Sorbet, R ;

Goldhaber, SZ ;

Morrison, RB ;

MacDougall, RC ;

Morrison, RM ;

Lamas, G ;

Bailey, K ;

Gersh, B ;

Pellegrino, E ;

Rick, M ;

Vaughan, D ;

Rosenberg, Y ;

Goldhaber, SZ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (15) :1425-1434

[10] The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event -: A meta-analysis [J].

van Dongen, CJJ ;

Hutten, BA ;

Büller, HR ;

Prins, MH .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (11) :1285-1293

← 1 →